Biocon still has steam, Asian Paints rally driven by short covering; private banks offer best value: Nuvama’s Nikhil Ranka

Asian Paints’ sharp rally, Biocon’s biosimilar boost, and improving valuations in private banks are reshaping market sentiment, says Nuvama’s CIO Nikhil Ranka. He explains why Biocon still has 10–15% upside, why Asian Paints may consolidate, and why large private banks now look attractive despite short-term NIM pressures. Read the full market outlook and sector-wise insights.